Pre-Open Stock Movers 12/30: (BNGO) (DNMR) (IMMP) Higher; (OSMT) (GEVO) Lower (more...)

Today's Pre-Open Stock Movers:

Bionano Genomics, Inc. (Nasdaq: BNGO) 31.6% HIGHER; announced today that Nasdaq has granted the Company an additional 180-day compliance period, or until June 28, 2021, to regain compliance with Nasdaq's minimum $1.00 closing bid price per share requirement.

Osmotica Pharmaceuticals plc (Nasdaq: OSMT) 26.3% LOWER; announced that the U.S. Food and Drug Administration has issued a Complete Response Letter regarding the Company's New Drug Application seeking approval for the investigational agent arbaclofen extended release tablets to treat spasticity resulting from multiple sclerosis.

Danimer Scientific (NYSE: DNMR) 21% HIGHER; completed its merger with SPAC Live Oak Acquisition Corp.

Gevo (NASDAQ: GEVO) 19% LOWER; entered into an amendment to the At-The-Market Offering Agreement, dated February 13, 2018, with H.C. Wainwright & Co., LLC, which provides for the issuance and sale from time to time of the Company’s common stock in an “at-the-market” offering. The Sales Agreement, among other things, provides for the issuance and sale under the ATM Offering of up to $150 million of shares of the Company’s common stock pursuant to the prospectus supplement, dated December 30, 2020.

Immutep Limited (NASDAQ: IMMP) 14.4% HIGHER; announce the grant of patent number 10,874,713 entitled Combined Preparations for the Treatment of Cancer or Infection by the United States Patent & Trade Mark Office.

DermTech, Inc. (NASDAQ: DMTK) 7.9% HIGHER; announced today that Geisinger Health System (Geisinger) has issued a positive medical benefit policy for its Commercial and Medicare Business Segment for the DermTech Pigmented Lesion Assay (PLA).

FinTech Acquisition Corp. IV (NASDAQ: FTIV) 6.4% HIGHER; Perella Weinberg Partners, a leading global independent advisory firm, and FinTech Acquisition Corp. IV (NASDAQ: FTIV) (FinTech IV), a special purpose acquisition company, announced today that they have entered into a definitive business combination agreement. Upon closing of the transaction, the combined company will operate as Perella Weinberg Partners and will be listed on NASDAQ under the new symbol PWP. The transaction reflects an implied equity value for the Company of approximately $975 million.

Rush Street Interactive, LP (NYSE: RSI) 4% HIGHER; completed its previously announced business combination with SPAC dMY Technology Group, Inc.

AstraZeneca's (NYSE: AZN) 1.4% HIGHER; The UK Government accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to approve the use of Oxford University/AstraZeneca's (NYSE: AZN) Covid-19 vaccine.

You May Also Be Interested In

• 23andMe (ME) stock jumps as CEO plans to take company private
• MediaCo (MDIA) Acquires Estrella Media’s Content and Digital Operations
• 23andMe (ME) CEO Wojcicki considering taking company private - 13D